Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study.
- DOI
- 10.1016/s2468-1253(19)30094-9
- Published
- 2019-03-26
- Container
- Lancet Gastroenterol Hepatol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s2468-1253-19-30094-9,
title = {Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study.},
author = {Trauner M and Nevens F and Shiffman ML and Drenth JPH and Bowlus CL and Vargas V and Andreone P and Hirschfield GM and Pencek R and Malecha ES and MacConell L and Shapiro D.},
year = {2019},
journal = {Lancet Gastroenterol Hepatol},
doi = {10.1016/s2468-1253(19)30094-9},
url = {https://doi.org/10.1016/s2468-1253(19)30094-9}
}RIS
TY - JOUR TI - Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study. AU - Trauner M AU - Nevens F AU - Shiffman ML AU - Drenth JPH AU - Bowlus CL AU - Vargas V AU - Andreone P AU - Hirschfield GM AU - Pencek R AU - Malecha ES AU - MacConell L AU - Shapiro D. PY - 2019 JO - Lancet Gastroenterol Hepatol DO - 10.1016/s2468-1253(19)30094-9 UR - https://doi.org/10.1016/s2468-1253(19)30094-9 ER -
APA
M, T., F, N., ML, S., JPH, D., CL, B., V, V., P, A., GM, H., R, P., ES, M., L, M., & D., S. (2019). Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study.. Lancet Gastroenterol Hepatol. https://doi.org/10.1016/s2468-1253(19)30094-9
Source records
- europe-pmc · retrieved 2026-09-27T16:00:03.641Z